Perrigo Absorbs Plant Remediation Sales Hit, But PBM Progresses In Q1
This article was originally published in The Tan Sheet
Executive Summary
Continuing remediation at a facility that received an FDA warning letter took a bite out of first-quarter sales for Perrigo, but the private labeler sees continued upside in branded competitor recalls and infant formula growth in the rest of fiscal 2011.